A new device aims to track the heart's pumping power in the ICU — without invasive tubes

NCT ID NCT07724262

Recruiting now Knowledge-focused Sponsor: Bicetre Hospital Source: ClinicalTrials.gov ↗

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This study tests whether the Argos system, a non-invasive monitor, can reliably measure changes in cardiac output (how much blood the heart pumps) in critically ill patients with shock. Researchers will compare its readings to those from a standard invasive device during fluid infusions or medication adjustments. If accurate, the Argos system could offer a simpler way to guide treatment in the intensive care unit.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If the Argos system proves reliable, it could offer a less invasive way to monitor heart function in intensive care patients.
What could go wrong: This is an early-stage observational study, not a treatment trial. The device may not match the accuracy of existing methods, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Shock

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SHOCK

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bicêtre Hospital
RECRUITING

Le Kremlin-Bicêtre, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.